| Year |
Citation |
Score |
| 2020 |
Zhou Y, Lian H, Shen N, Korm S, Lam AKP, Layton O, Huiting LN, Li D, Miao K, Zeng A, Landesman-Bollag E, Seldin DC, Fu H, Hong L, Feng H. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia. Haematologica. PMID 32817283 DOI: 10.3324/Haematol.2020.246918 |
0.582 |
|
| 2016 |
Lian H, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, Tang KC, Roderick JE, Kelliher MA, Seldin DC, Fu H, Feng H. CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica. PMID 27758824 DOI: 10.3324/Haematol.2016.154013 |
0.525 |
|
| 2016 |
Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ, Sherr DH. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. Bmc Biology. 14: 20. PMID 26984638 DOI: 10.1186/S12915-016-0240-Y |
0.542 |
|
| 2013 |
Seldin DC, Landesman-Bollag E. The Oncogenic Potential of CK2 Protein Kinase Ck2. 292-304. DOI: 10.1002/9781118482490.ch10 |
0.504 |
|
| 2012 |
Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Research. 72: 6268-78. PMID 23054396 DOI: 10.1158/0008-5472.Can-12-2270 |
0.6 |
|
| 2011 |
Landesman-Bollag E, Belkina A, Hovey B, Connors E, Cox C, Seldin DC. Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes. Molecular and Cellular Biochemistry. 356: 227-31. PMID 21769451 DOI: 10.1007/S11010-011-0967-2 |
0.701 |
|
| 2008 |
Seldin DC, Lou DY, Toselli P, Landesman-Bollag E, Dominguez I. Gene targeting of CK2 catalytic subunits. Molecular and Cellular Biochemistry. 316: 141-7. PMID 18594950 DOI: 10.1007/S11010-008-9811-8 |
0.792 |
|
| 2008 |
Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O'Brien C, Seldin DC. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Molecular and Cellular Biology. 28: 131-9. PMID 17954558 DOI: 10.1128/Mcb.01119-07 |
0.804 |
|
| 2005 |
Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Research. 65: 11375-83. PMID 16357145 DOI: 10.1158/0008-5472.Can-05-1602 |
0.65 |
|
| 2005 |
Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Molecular and Cellular Biochemistry. 274: 63-7. PMID 16342409 DOI: 10.1007/S11010-005-3078-0 |
0.723 |
|
| 2005 |
Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Molecular and Cellular Biology. 25: 10136-47. PMID 16260626 DOI: 10.1128/Mcb.25.22.10136-10147.2005 |
0.606 |
|
| 2005 |
Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Research. 65: 5792-801. PMID 15994955 DOI: 10.1158/0008-5472.Can-05-1021 |
0.767 |
|
| 2003 |
Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Molecular and Cellular Biology. 23: 5738-54. PMID 12897145 DOI: 10.1128/Mcb.23.16.5738-5754.2003 |
0.632 |
|
| 2002 |
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Research. 62: 6770-8. PMID 12438279 |
0.613 |
|
| 2002 |
Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. The American Journal of Pathology. 161: 1087-97. PMID 12213737 DOI: 10.1016/S0002-9440(10)64269-1 |
0.608 |
|
| 2002 |
Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 21: 5548-56. PMID 12165853 DOI: 10.1038/Sj.Onc.1205686 |
0.625 |
|
| 2001 |
Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC. Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Molecular and Cellular Biochemistry. 227: 153-65. PMID 11827167 DOI: 10.1023/A:1013108822847 |
0.733 |
|
| 2001 |
Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene. 20: 3247-57. PMID 11423974 DOI: 10.1038/Sj.Onc.1204411 |
0.767 |
|
| 2001 |
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Research. 61: 3810-8. PMID 11325857 |
0.62 |
|
| 2000 |
Ford HL, Landesman-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB, Seldin DC. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. The Journal of Biological Chemistry. 275: 22245-54. PMID 10801845 DOI: 10.1074/Jbc.M002446200 |
0.586 |
|
| 1999 |
Xu X, Landesman-Bollag E, Channavajhala PL, Seldin DC. Murine protein kinase CK2: gene and oncogene. Molecular and Cellular Biochemistry. 191: 65-74. PMID 10094394 DOI: 10.1007/978-1-4419-8624-5_9 |
0.791 |
|
| 1998 |
Rifkin IR, Channavajhala PL, Kiefer HL, Carmack AJ, Landesman-Bollag E, Beaudette BC, Jersky B, Salant DJ, Ju ST, Marshak-Rothstein A, Seldin DC. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. Journal of Immunology (Baltimore, Md. : 1950). 161: 5164-70. PMID 9820486 |
0.764 |
|
| 1998 |
Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene. 16: 2965-74. PMID 9662328 DOI: 10.1038/Sj.Onc.1201854 |
0.779 |
|
| Show low-probability matches. |